Endocrine oncology

Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer

ThyroidPublished Retrospective cohort study

Authors' conclusion

The presence of prior malignancy does not significantly impact OS in patients with ATC.

Study context

Population
Patients with anaplastic thyroid cancer (ATC) treated at MD Anderson between 2000 and 2019
Participants
451 patients
Exposure
Prior or concomitant malignancy vs none
  • Prior differentiated thyroid cancer (DTC)n = 62
  • Concomitant DTCn = 234
  • Prior nonthyroid cancern = 102
Outcome
OS
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

OS (multivariate analysis adjusted for age and overall stage)
  • Prior DTC, concomitant DTC and prior nonthyroid cancers all had no significant impact on overall survival (OS)

Observational data: associations, not effects.

Further findings

Prevalence of prior and concomitant cancers

Median, years

OutcomePrior DTCConcomitant DTCPrior nonthyroid cancer
Time from prior cancer diagnosis to ATC diagnosis3.5 (range 6 months to 35 years)— not stated in the abstract8 (range 3 months to 53 years)

— not stated in the abstract

Prevalence of prior and concomitant cancers — Prior DTC that was papillary thyroid cancer
81%, n = 50
Prevalence of prior and concomitant cancers — One / two / three prior nonthyroid cancers
19% (n = 87) / 2% (n = 10) / 1% (n = 5)
Prevalence of prior and concomitant cancers — Most common prior nonthyroid cancers: nonmelanoma skin / prostate / breast
28.4% / 19.6% / 16.7%

Tumor driver mutations (BRAF, RAS, TP53), subgroup with mutation information (n = 183)

Frequency not significantly different between ATC with and without history of nonthyroid cancer

Original publication

Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer. Thyroid. Published 20 February 2023. doi:10.1089/thy.2022.0350

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.